Gabon vs Sur: Hepatitis B surface antigen (HBsAg) prevalence
Gabon
3.2%
in 2024
Sur
0.2%
in 2024
Gabon rank
3rd
Sur rank
1st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Gabon
- Sur
How they compare
Gabon currently reports 3.2% against 0.2% in Sur, a difference of 3.0%.
That makes Gabon's figure about 16.0 times Sur's.
Across all 10 years both countries report, Gabon has been ahead every year.
Gabon ranks 3rd and Sur ranks 1st of 194 countries.
Gabon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.9% | 0.2% | 2.7% | Gabon |
| 2020s | 3.1% | 0.2% | 2.9% | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Gabon or Sur?
- Gabon, at 3.2% against 0.2% in Sur as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Gabon and Sur?
- 3.0%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Sur?
- 10 years are reported by both, from 2015 to 2024.
- How do Gabon and Sur rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Gabon ranks 3rd and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.